{"id":13225,"date":"2024-08-23T03:10:11","date_gmt":"2024-08-23T01:10:11","guid":{"rendered":"https:\/\/valintermed.com\/?p=13225"},"modified":"2024-08-23T03:10:11","modified_gmt":"2024-08-23T01:10:11","slug":"tirozinemiya-tip-3","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/tyrosinemia-type-3\/","title":{"rendered":"Tyrosinemia type 3"},"content":{"rendered":"
<\/div>\n

Tyrosinemia type 3 is a rare genetic disorder that belongs to a group of amino acid metabolism disorders associated with abnormal tyrosine metabolism. Unlike the more common forms of tyrosinemia, such as type 1 and type 2, tyrosinemia type 3 is characterized by specific mutations leading to a deficiency of the enzyme 4-hydroxyresorcinol and further metabolic disturbances. The development of this disease is associated with the accumulation of intermediate metabolites of tyrosine, which can lead to disturbances in various organs and tissues, including the liver and nervous system. Clinical manifestations of tyrosinemia type 3 can range from moderate to severe, including neurological disorders, making it an important subject for medical research and diagnosis in the early stages. <\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n